Trade Mark Journal No.2026/029 17 July 2026

UK00004383912 7 May 2026 (5,10,35,42,44)

ZENITH

International priority date claimed: 27 January 2026 (United States of America) (99617636)
Class 5
Diagnostic preparations for medical purposes; Diagnostic reagents for medical purposes; Diagnostic kits comprising diagnostic agents, preparations and substances for medical use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, detecting rare diseases.
Class 10
Medical diagnostic apparatus for detecting cancer; Blood testing apparatus, namely, blood collecting tubes; Medical diagnostic apparatus for testing for rare diseases.
Class 35
Business consulting services in the field of healthcare; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes.
Class 42
Providing medical and scientific research information; Medical and scientific research in the field of genetic testing; Genetic testing for scientific research purposes; Providing a website featuring educational information in the field of clinical research; Providing information about medical research in the field of genetic testing and oncology; Software as a service (SAAS) services featuring software for collecting, verifying, storing, analyzing, and transmitting information and reports concerning genetics, genetic mutations, genetic test results, diagnoses and treatments.
Class 44
Genetic testing for medical purposes; Genetic counseling; Medical laboratory analysis services relating to the treatment of persons; Providing information about genetic testing for medical purposes; Providing health information in the field of genetic testing and oncology; Genetic testing for cancer risk for medical purposes; Medical analysis services for the diagnosis of cancer; Medical analysis for the diagnosis and treatment of persons; Providing information in the field of the diagnosis and treatment of cancer via a website; Providing a web site featuring medical information; Providing a website featuring information in the field of the diagnosis and treatment of rare diseases.

Natera, Inc.

Representative: J A Kemp LLP